These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1919160

  • 1. Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment.
    Taradi M, Urano M, Taradi SK, Maruyama Y.
    Int J Hyperthermia; 1991; 7(4):653-65. PubMed ID: 1919160
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of the thermal response of murine tumour and normal tissues by a streptococcal preparation, OK-432 (Picibanil).
    Urano M, Taradi M, Taradi SK.
    Int J Hyperthermia; 1991; 7(1):113-23. PubMed ID: 2051067
    [Abstract] [Full Text] [Related]

  • 3. Analysis of antitumor effects of OK-432 against syngeneic mouse fibrosarcoma: combination effect of OK-432 and recombinant lymphokines.
    Nanjo M, Moriya Y, Hashimoto S, Kataoka M, Saito M, Yoshida T, Ishida N.
    Int J Immunopharmacol; 1991; 13(2-3):205-15. PubMed ID: 1906439
    [Abstract] [Full Text] [Related]

  • 4. Effect of thermoimmunotherapy with OK-432 on the development of spontaneous lung metastases in mice.
    Taradi SK, Taradi M, Urano M.
    Int J Hyperthermia; 1992; 8(2):221-6. PubMed ID: 1573311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
    Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec 20; 24(11):2546-55. PubMed ID: 2614190
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
    Saito M, Nanjo M, Kataoka M, Moriya Y, Sugawara Y, Yoshida T, Ishida N.
    Cancer Res; 1988 Aug 01; 48(15):4163-7. PubMed ID: 3390809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 01; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of radiation therapy combined with natural killer cells against spontaneous murine fibrosarcoma.
    Nakagawa K, Yoshida F, Omori N, Tsunoda T, Nose T.
    Biotherapy; 1990 Aug 01; 2(1):69-75. PubMed ID: 2205258
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
    Bonavida B, Katz J, Hoshino T.
    Cell Immunol; 1986 Oct 01; 102(1):126-35. PubMed ID: 3492275
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.